pharma · HIV Infections · Major Depressive Disorder · PRAX
Praxis Precision Medicines
Praxis Precision Medicines is a pharma organization headquartered in Boston, USA. It trades on NYSE under ticker PRAX. Primary therapeutic focus areas include HIV Infections, Major Depressive Disorder, Pancreatic Cancer,
Boston, USA HQ
205 Employees
Public company Type
PRAX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Employees
- 205
- Programs
- 7
- Drugs
- 8
- Patents
- 35
HIV-1 C4-V3 Polyvalent Peptide Vaccine
Phase 1 · mab · HIV Infections
HIV-1 C4-V3 Polyvalent Peptide Vaccine for HIV Infections is a Phase 1 program (mab) at Praxis Precision Medicines with 1 ClinicalTrials.gov record(s).
Internal code DATRI 101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Praxis Precision Medicines
- Phase
- Phase 1
- Modality
- mab
- Indication
- HIV Infections
- Status
- completed
- Trials
- 1